The Treatment of Negative Symptoms: Pharmacological and Methodological Issues
- 1 May 1996
- journal article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 168 (S29) , 17-22
- https://doi.org/10.1192/s0007125000298279
Abstract
The drugs currently used to treat the negative symptoms of schizophrenia are inadequate, and the methods used to evaluate their efficacy impractical and conceptually flawed. I will attempt to clarify these issues, but they are complex, and the solutions I suggest will not be completely satisfactory.Keywords
This publication has 42 references indexed in Scilit:
- Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double‐blind comparative studyActa Psychiatrica Scandinavica, 1992
- Ventricular enlargement, clinical correlates and treatment outcome in chronic schizophrenic inpatientsActa Psychiatrica Scandinavica, 1992
- The deficit state in a prospective study of first-episode schizophreniaSchizophrenia Research, 1992
- Reliability and validity of the positive and negative syndrome scale for schizophrenicsPsychiatry Research, 1988
- The Symptoms of Chronic SchizophreniaThe British Journal of Psychiatry, 1987
- A standardized psychiatric assessment scale for rating chronic psychotic patientsActa Psychiatrica Scandinavica, 1977
- 6-Hydroxydopamine, Noradrenergic Reward, and SchizophreniaScience, 1972